What are the risks associated with World Health Organization (WHO) Class III cardiac disease during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

WHO Class III Cardiac Risk in Pregnancy

Women with WHO Class III cardiac disease face significantly increased risk of maternal mortality or severe morbidity during pregnancy, with cardiac complications occurring in 12-43% of cases and requiring expert multidisciplinary management throughout pregnancy. 1

Magnitude of Risk

WHO Class III represents a high-risk category where pregnancy carries substantial danger but is not absolutely contraindicated (unlike Class IV). The specific risks include:

Maternal Cardiovascular Complications

  • Cardiac event rates: 12.2-42.9% across multiple validation studies 2, 3
  • Congestive heart failure is the most common complication 3
  • Arrhythmias requiring intervention
  • Thromboembolic events (particularly with mechanical valves)
  • Stroke risk
  • Maternal mortality, though rare with expert care, remains elevated compared to lower WHO classes 3

Obstetric and Delivery Complications

  • Preterm delivery: significantly increased (3-8 fold higher than Class I/II) 4, 2, 5
  • Cesarean section rate: 3.4 times higher than controls 4
  • Preeclampsia: 3.8 times higher risk 4
  • Emergency interventions more frequently required

Fetal and Neonatal Risks

  • Low birth weight infants 5, 3
  • Small for gestational age 3
  • NICU admission rates significantly elevated 3
  • Neonatal complications occur in 20-28% of pregnancies with maternal heart disease, with mortality 1-4% 1

Specific WHO Class III Conditions

The following cardiac conditions are classified as WHO Class III 1:

  • Mechanical heart valves (anticoagulation challenges)
  • Systemic right ventricle (e.g., transposition after atrial switch)
  • Fontan circulation (single ventricle palliation)
  • Cyanotic heart disease (unrepaired)
  • Complex congenital heart disease
  • Aortic dilatation 40-45 mm in Marfan syndrome
  • Aortic dilatation 45-50 mm with bicuspid aortic valve

Critical Management Requirements

Monthly or bimonthly cardiology and obstetric review is mandatory throughout pregnancy for WHO Class III patients 1. This is non-negotiable and distinguishes Class III from lower-risk classes that require only trimester-based follow-up.

Pre-Pregnancy Counseling

Expert counseling is required before conception 1, 6. This must include:

  • Quantified risk of maternal mortality and severe morbidity
  • Discussion of cardiac event rates (12-43%)
  • Medication review and adjustment (teratogenic drugs must be changed)
  • Optimization of cardiac function before conception
  • Discussion with patient and partner about risks

Delivery Planning

  • Hospital delivery is mandatory 1
  • Delivery must occur at a specialist tertiary center with multidisciplinary expertise 1, 2
  • Cesarean section is often performed for cardiac indications (not just obstetric) 5
  • Anesthesia team experienced in cardiac disease must be involved

Team Composition

The multidisciplinary team must include 1:

  • Cardiologist with expertise in pregnancy and heart disease
  • Maternal-fetal medicine specialist
  • Experienced obstetrician
  • Cardiac anesthesiologist
  • Neonatology team on standby

Common Pitfalls to Avoid

  1. Underestimating risk: Class III is NOT "moderate risk"—it represents significantly increased mortality/severe morbidity risk
  2. Inadequate follow-up frequency: Trimester-based visits are insufficient; monthly/bimonthly is required
  3. Delivery at non-specialist centers: Community hospitals lack the expertise and resources for these high-risk deliveries
  4. Failure to involve cardiology early: Joint management from early pregnancy is essential, not just consultation when problems arise
  5. Inadequate preconception counseling: Women must understand risks BEFORE pregnancy when all options remain available

Evidence Quality

The modified WHO classification has been validated in multiple international cohorts 4, 3, 7 and demonstrates superior discrimination compared to other risk scores (c-statistic 0.827) 7. The ESC guidelines [1-1] represent the most comprehensive evidence-based framework, though published in 2011. More recent validation studies from 2018-2025 4, 2, 3 confirm the classification's continued clinical utility and accuracy in predicting adverse outcomes.

The consistent finding across all studies is that WHO Class III represents a threshold where pregnancy complications become common rather than exceptional, necessitating intensive monitoring and specialist care throughout pregnancy and the peripartum period.

References

5
Research

Clinical analyses of 383 cases with maternal cardiac diseases.

Journal of perinatal medicine, 2018

7
Research

Comparison of 3 Risk Estimation Methods for Predicting Cardiac Outcomes in Pregnant Women With Congenital Heart Disease.

Circulation journal : official journal of the Japanese Circulation Society, 2015

Related Questions

Is a preoperative electrocardiogram (ECG) necessary for a 57‑year‑old patient with no known cardiac disease who smokes and consumes alcohol undergoing total joint revision surgery?
What are the indications, contraindications, and peri‑procedural precautions for administering electroconvulsive therapy (ECT) in a patient with cardiac disease?
What are the 2025 ACC/AHA guideline recommendations for blood pressure targets, lipid management, heart failure therapy, post‑myocardial infarction secondary prevention, stable coronary artery disease, and atrial fibrillation anticoagulation in adults?
In an asymptomatic high‑performance athlete without known cardiac disease, should a resting 12‑lead electrocardiogram (ECG) be performed first, and when is a transthoracic echocardiogram (TTE) indicated?
In a fluid‑restricted infant with cardiac disease, does using a more concentrated formula increase the risk of constipation?
Can night sweats develop four months after initiating an SSRI?
What is the appropriate apixaban dose for thromboprophylaxis adjusted for creatinine clearance?
Can pernicious anemia present with high transferrin saturation (>55%) and elevated serum iron (>200 µg/dL), thereby mimicking hereditary hemochromatosis?
What is the recommended method for titrating insulin aspart upward, including dose increments, timing with meals, target glucose ranges, and monitoring for hypoglycemia?
Should I change the topical antibiotic from erythromycin to a broad‑spectrum fluoroquinolone for a patient with a large corneal abrasion who now has blurred vision and fluorescein staining showing corneal and peri‑ocular uptake?
Does Lokelma (sodium zirconium cyclosilicate) raise blood pressure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.